Clinical trial
Safety and Efficacy of Trametinib for Complicated Vascular Anomalies: A Multicenter Prospective Study
NCT07072403 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Trametinib for Complicated Vascular Anomalies: A Multicenter Prospective Study
- Lead sponsor
- West China Hospital
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- July 7, 2025
- Completion date
- September 1, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vascular anomalies